{"schema":"abhortion.org/legislation.full/v1","id":"legality-us-federal","type":"legislation","level":"federal","jurisdiction":"United States (federal)","as_of_date":"2026-07-12","research_completed_date":"2026-07-12","headline":"States regulate; federal levers remain","summary":"After Dobbs, there is no federal constitutional abortion right; Congress has not enacted a national ban or a national codification, leaving states as primary regulators while FDA approval, spending riders, EMTALA, the Comstock Act, and conscience laws operate as key federal levers.","machine_readable_summary":{"constitutional_right_status":"none_post_dobbs","federal_gestational_ban":false,"partial_birth_ban_in_effect":true,"mifepristone_fda_approved":true,"mifepristone_telehealth_rems":"allowed","comstock_act_enforced":"not_currently","hyde_amendment_in_effect":true,"emtala_preemption_resolved":false,"federal_personhood_law":false,"interstate_travel_protected":"presumed"},"links":{"html":"https://www.abhortion.org/legislation/federal.html","markdown":"https://www.abhortion.org/legislation/federal.md","summary_json":"https://www.abhortion.org/legislation/federal.json","full_json":"https://www.abhortion.org/legislation/federal-full.json","verbose_json":"https://www.abhortion.org/legislation/federal-verbose.json"},"overview":{"title":"States regulate; federal levers remain","summary":"After Dobbs, there is no federal constitutional abortion right; Congress has not enacted a national ban or a national codification, leaving states as primary regulators while FDA approval, spending riders, EMTALA, the Comstock Act, and conscience laws operate as key federal levers.","description":"Since the Supreme Court's 2022 Dobbs decision, there is no federal constitutional right to abortion. The federal government has not passed a law either banning abortion nationwide or protecting it nationwide. That means each state now makes its own abortion laws. But federal law still matters in several important ways: the FDA decides whether abortion pills are approved and how they can be prescribed and dispensed; Congress uses spending bills to block most federal funds from paying for abortions; a law called EMTALA requires hospitals to provide emergency care—and the question of whether that includes abortion in ban states is still being fought in court; an old law called the Comstock Act could be revived to restrict mailing of abortion pills; and federal conscience laws protect health care workers who refuse to participate in abortion.","verification":"verified","confidence":"high","sources":[{"name":"Supreme Court of the United States","href":"https://www.supremecourt.gov/opinions/21pdf/19-1392_6j37.pdf"}]},"sections":{"dobbs_baseline":{"title":"No constitutional right; rational basis","summary":"Dobbs overruled Roe and Casey, holding the Constitution confers no abortion right; post-Dobbs, state abortion laws are reviewed under rational-basis scrutiny, and the Court expressly reserved the interstate-travel and medication-preemption questions.","description":"In June 2022, the U.S. Supreme Court decided Dobbs v. Jackson Women's Health Organization, overturning nearly 50 years of precedent. The Court ruled that the U.S. Constitution does not protect a right to abortion. This means there is no longer a federal constitutional floor for abortion access. The Court sent the issue back to each state to decide its own laws, and to Congress if it chooses to act. Going forward, courts will review state abortion laws using the most deferential standard—\"rational basis\"—meaning a law will be upheld if it is rationally related to a legitimate government interest. The Court explicitly said it was not deciding questions about traveling across state lines for an abortion or whether FDA approval of abortion drugs overrides state bans.","verification":"verified","confidence":"high","sources":[{"name":"Supreme Court of the United States","href":"https://www.supremecourt.gov/opinions/21pdf/19-1392_6j37.pdf"},{"name":"Supreme Court of the United States (via Akhil Amar site)","href":"https://akhilamar.com/wp-content/uploads/2023/09/Kavanaugh-concurrence-Dobbs.pdf"}]},"definitions":{"title":"Born-alive definition only; no fetal personhood","summary":"Federal law defines 'person,' 'human being,' 'child,' and 'individual' to include every infant born alive at any stage of development, but there is no federal statute defining the unborn as 'persons' for general purposes; the Unborn Victims of Violence Act creates a separate fetal-homicide offense while expressly excluding consensual abortion and the mother from its scope.","description":"Federal law defines when a baby who is born counts as a legal 'person'—that includes any infant who is born alive at any stage of development and shows signs of life like breathing or a heartbeat. This definition applies when interpreting all federal laws and regulations. But this definition explicitly says it does not address any legal status before birth. There is no federal law that says an embryo or fetus is a 'person' for all purposes. The Unborn Victims of Violence Act makes it a separate federal crime to kill or injure an unborn child during certain violent federal crimes—but the law says it does not apply to any abortion the pregnant woman consented to, to any act by the pregnant woman herself, or to any medical treatment.","verification":"verified","confidence":"high","sources":[{"name":"U.S. Government Publishing Office (govinfo)","href":"https://www.govinfo.gov/link/uscode/1/8"},{"name":"U.S. House of Representatives (uscode.house.gov)","href":"https://uscode.house.gov/view.xhtml?req=(title:18%20section:1841%20edition:prelim)%20OR%20(granuleid:USC-prelim-title18-section1841)&f=treesort&num=0&edition=prelim"}]},"statutory_landscape":{"partial_birth_abortion_ban":{"title":"D&X method banned; mother exempt","summary":"The Partial-Birth Abortion Ban Act of 2003, 18 U.S.C. § 1531, prohibits a specific late-term procedure—intact dilation and extraction—nationwide, with a life-of-the-mother exception and no prosecution of the pregnant woman.","description":"Federal law bans a specific late-term abortion procedure called 'partial-birth abortion'—medically known as intact dilation and extraction—everywhere in the United States. This ban applies only to physicians who knowingly perform this specific procedure. There is an exception when the procedure is necessary to save the pregnant woman's life. The law explicitly says the woman who undergoes the procedure cannot be prosecuted. The Supreme Court upheld this ban as constitutional in 2007.","verification":"verified","confidence":"high","sources":[{"name":"Legal Information Institute (Cornell Law School)","href":"https://www.law.cornell.edu/uscode/text/18/1531"},{"name":"Justia","href":"https://supreme.justia.com/cases/federal/us/550/124/"}]},"comstock_act":{"title":"Not enforced for lawful use; disputed","summary":"18 U.S.C. §§ 1461-1462 declare abortion-related articles 'nonmailable,' but the DOJ Office of Legal Counsel concluded in December 2022 that the Act does not prohibit mailing abortion drugs where the sender lacks intent that they be used unlawfully—a reading that could shift with a new administration.","description":"The Comstock Act is a federal law from 1873 that says it is illegal to mail any article, drug, or substance intended for producing abortion. For decades, federal courts interpreted this law narrowly, saying it only applies when the sender intends the items to be used for an illegal abortion. In December 2022, the Justice Department's Office of Legal Counsel issued an opinion confirming that the Comstock Act does not bar mailing the abortion drugs mifepristone and misoprostol where the sender lacks intent that the drugs will be used unlawfully—and because the drugs can be used lawfully in every state (for miscarriage management, for example), the mere mailing of them does not prove illegal intent. However, this interpretation is not binding on future administrations. Anti-abortion advocates have called for a future Republican administration to reinterpret the Comstock Act as an outright ban on mailing abortion-related materials, which could sharply restrict medication abortion nationwide. The 2025 Trump administration has not yet altered the OLC's 2022 opinion, but the issue remains intensely debated.","verification":"verified","confidence":"medium","sources":[{"name":"Legal Information Institute (Cornell Law School)","href":"https://www.law.cornell.edu/uscode/text/18/1461"},{"name":"U.S. Department of Justice, Office of Legal Counsel","href":"https://www.justice.gov/olc/opinion/file/1560596/dl"}]},"hyde_amendment_and_riders":{"title":"Federal funds barred except rape, incest, life","summary":"The Hyde Amendment, an annual appropriations rider, bars using federal funds for abortion except in cases of rape, incest, or life endangerment; companion riders extend similar restrictions to the FEHBP, D.C., foreign aid, and conscience protections.","description":"Since 1976, Congress has included a provision called the Hyde Amendment in its annual spending bills. It says no federal money can be used to pay for abortions, with three exceptions: when the pregnancy results from rape, when it results from incest, or when continuing the pregnancy would endanger the woman's life. This affects people covered by Medicaid, Medicare, the Children's Health Insurance Program, and other federal health programs. Similar restrictions apply to federal employees' health insurance (the Smith/Dornan Amendment), military health care, foreign aid (the Helms Amendment), and the Indian Health Service. The Hyde Amendment is not a permanent statute—it Must be renewed every year as part of the budget process. Additional riders such as the Weldon Amendment protect health care entities from discrimination for refusing to provide or refer for abortions.","verification":"verified","confidence":"high","sources":[{"name":"The White House","href":"https://www.whitehouse.gov/presidential-actions/2025/01/enforcing-the-hyde-amendment"},{"name":"U.S. Department of Justice, Office of Legal Counsel","href":"https://www.justice.gov/olc/media/1408241/dl"}]},"unborn_victims_act":{"title":"Fetal-homicide offense; abortion exempt","summary":"The Unborn Victims of Violence Act, 18 U.S.C. § 1841, makes it a separate federal crime to kill or injure a 'child in utero' during certain federal crimes of violence, but expressly excludes consensual abortion and acts by the pregnant woman.","description":"This federal law says that if someone commits one of about 60 listed violent federal crimes and, in the process, kills or injures an unborn child, they can be charged with a separate crime on top of any charge related to harming the pregnant woman. But the law is clear: it does not apply to any abortion the woman consented to, to any act by the pregnant woman herself, or to any medical treatment. So the law recognizes an unborn child as a potential victim of violence for criminal prosecution purposes without affecting abortion rights or medical care.","verification":"semi_verified","confidence":"high","sources":[{"name":"U.S. House of Representatives (uscode.house.gov)","href":"https://uscode.house.gov/view.xhtml?req=(title:18%20section:1841%20edition:prelim)%20OR%20(granuleid:USC-prelim-title18-section1841)&f=treesort&num=0&edition=prelim"}]},"church_amendments_conscience":{"title":"Strong provider refusal protections","summary":"Multiple federal statutes—the Church Amendments (42 U.S.C. § 300a-7), the Coats-Snowe Amendment (42 U.S.C. § 238n), and the Weldon Amendment—protect individuals and health care entities that refuse to participate in abortion from discrimination and certain governmental requirements.","description":"Federal law includes several protections for health care workers, institutions, and insurers who object to abortion on religious or moral grounds. The Church Amendments, passed in the 1970s, say that receiving federal funds does not allow courts or public officials to require any individual to perform or assist in an abortion if it goes against their religious or moral beliefs, nor to require institutions to make their facilities available for abortion or provide personnel for it. The amendments also ban discrimination against medical professionals—in employment, promotion, or staff privileges—because they performed or refused to perform an abortion. The Coats-Snowe Amendment adds that federal and state governments receiving federal money cannot discriminate against medical training programs or entities that refuse to train in, perform, or refer for abortions. The Weldon Amendment, an annual budget rider, extends these conscience protections further to health insurance plans and other health care entities.","verification":"verified","confidence":"high","sources":[{"name":"U.S. House of Representatives (uscode.house.gov)","href":"https://uscode.house.gov/view.xhtml?req=granuleid%3AUSC-prelim-title42-section300a-7&num=0&edition=prelim"},{"name":"U.S. House of Representatives (uscode.house.gov)","href":"https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section238n&num=0&edition=prelim"}]},"born_alive_and_other":{"title":"Born-alive definition; FACE clinic protections","summary":"1 U.S.C. § 8 defines 'born alive' for all federal law purposes; the FACE Act, 18 U.S.C. § 248, criminalizes force or obstruction against reproductive health clinics and patients, though the Trump DOJ sharply limited its enforcement in 2025.","description":"Two additional federal statutes round out the statutory picture. The Born-Alive Infants Protection Act says that for all federal laws, 'person,' 'human being,' 'child,' and 'individual' include every infant born alive at any stage of development, including after an abortion. The Freedom of Access to Clinic Entrances (FACE) Act makes it a federal crime to use force, threats, or physical obstruction to interfere with someone seeking or providing reproductive health services. FACE also allows victims and the U.S. Attorney General to bring civil lawsuits. In January 2025, however, the Trump Justice Department announced it would bring new FACE Act prosecutions only in 'extraordinary circumstances,' a policy shift that abortion-rights advocates say effectively greenlights clinic obstruction.","verification":"verified","confidence":"high","sources":[{"name":"Legal Information Institute (Cornell Law School)","href":"https://www.law.cornell.edu/uscode/text/18/248"},{"name":"U.S. Department of Justice","href":"https://www.justice.gov/media/1386461/dl"}]}},"fda_and_medication":{"mifepristone_approval":{"title":"FDA-approved; REMS allows telehealth, mail","summary":"Mifepristone is FDA-approved (2000) for medication abortion through 10 weeks gestation; the REMS was modified in January 2023 to permanently remove the in-person dispensing requirement and permit certified retail and mail-order pharmacies to dispense.","description":"The FDA first approved mifepristone—also called the abortion pill—in 2000 for ending early pregnancies up to 10 weeks, used together with a second drug called misoprostol. A generic version was approved in 2019, and a second generic was approved in September 2025. For many years, the FDA required that the pill be dispensed in person at a clinic or hospital. In January 2023, the FDA permanently removed that requirement. Now, certified pharmacies—including mail-order pharmacies—can dispense mifepristone directly to patients with a prescription from a certified prescriber. This means people in states where abortion is legal can get medication abortion via telehealth and receive pills by mail. However, in states with abortion bans, these changes do not override state law, and the practical availability of the pills through mail depends on the interplay of state laws and the Comstock Act debate.","verification":"semi_verified","confidence":"high","sources":[{"name":"U.S. Food and Drug Administration","href":"https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/information-about-mifepristone-medical-termination-pregnancy-through-ten-weeks-gestation"},{"name":"U.S. Food and Drug Administration (accessdata.fda.gov)","href":"https://www.accessdata.fda.gov/drugsatfda_docs/summary_review/2023/020687Orig1s025SumR.pdf"}]},"ahm_v_fda":{"title":"Standing denied; state case continues","summary":"In FDA v. Alliance for Hippocratic Medicine (2024), the Supreme Court unanimously held that the plaintiff doctors lacked Article III standing, leaving FDA approval intact; a parallel case brought by three states (Missouri, Idaho, Kansas) continues in Missouri federal court.","description":"In June 2024, the U.S. Supreme Court threw out a major lawsuit that had tried to overturn the FDA's approval of mifepristone and its more recent rules making the pill easier to get. The Court ruled unanimously that the anti-abortion doctors who brought the case did not have legal standing—meaning they were not directly harmed enough to sue. This preserved the FDA's approval of the drug, at least for now. However, a separate lawsuit brought by the states of Missouri, Idaho, and Kansas is still moving forward. They argue the FDA's handling of mifepristone violates federal law and the Comstock Act. That case was transferred in 2025 from Texas to federal court in Missouri and is still being litigated. The FDA's approval of mifepristone therefore remains in effect but faces ongoing legal challenge.","verification":"semi_verified","confidence":"medium","sources":[{"name":"Supreme Court of the United States","href":"https://www.supremecourt.gov/opinions/23pdf/23-235_n7lp.pdf"},{"name":"Health Care Litigation Tracker (Georgetown Law)","href":"https://litigationtracker.law.georgetown.edu/litigation/state-of-missouri-et-al-v-food-and-drug-administration-et-al"}]},"preemption":{"title":"No preemption of state bans; Fourth Circuit","summary":"In GenBioPro v. Raynes (4th Cir. July 2025), a divided panel held that FDA approval of mifepristone does not preempt West Virginia's near-total abortion ban; the Supreme Court has not yet addressed the preemption question.","description":"The maker of generic mifepristone sued West Virginia, arguing that the state's abortion ban cannot block access to a drug the FDA has approved as safe and effective—that federal law should override the state ban. In July 2025, a federal appeals court in Richmond ruled against the drug company, finding that West Virginia's abortion ban is not preempted by the FDA's approval of mifepristone. In a 2-1 decision, the court said that states have traditionally regulated the practice of medicine, and the FDA's drug-approval power does not give it authority to override state decisions about whether particular medical procedures are legal. This is a major ruling but is not from the Supreme Court; the company could appeal further. The preemption question is also being litigated in separate cases in North Carolina and other courts, and the Supreme Court has not yet resolved it.","verification":"verified","confidence":"medium","sources":[{"name":"Justia","href":"https://law.justia.com/cases/federal/appellate-courts/ca4/23-2194/23-2194-2025-07-15.html"}]}},"emtala":{"title":"Unresolved; Moyle DIG, Texas cert denied","summary":"Whether EMTALA requires hospitals in ban states to provide emergency abortions remains legally unresolved: the Supreme Court dismissed Moyle v. United States as improvidently granted (June 2024), and in Texas v. Becerra the Court denied certiorari (October 2024), leaving a circuit split and no definitive federal ruling.","description":"EMTALA is a federal law that requires nearly all hospitals with emergency departments to provide stabilizing treatment to any patient with a medical emergency. The Biden administration argued that in rare cases, this includes abortion care—even in states that ban abortion—when the pregnancy causes a medical emergency that seriously threatens the woman's health. This set up a direct conflict with state abortion bans. The Supreme Court had the chance to settle the question in 2024 but didn't. In the Idaho case, the Court sent the case back to the lower courts without deciding the main issue. In the Texas case, the Court refused to hear the Biden administration's appeal, leaving in place a lower-court ruling that blocks the federal government from enforcing its EMTALA abortion guidance in Texas. The practical result is a mess: in some ban states, doctors are uncertain about when they can legally provide emergency abortion care, and women with severe pregnancy complications are sometimes being airlifted to other states for treatment rather than receiving it locally. The legal question remains open and will return to the Supreme Court, likely in a different case or with a different administration.","verification":"verified","confidence":"medium","sources":[{"name":"Supreme Court of the United States","href":"https://www.supremecourt.gov/opinions/23pdf/23-726_6jgm.pdf"},{"name":"Supreme Court of the United States / Fifth Circuit","href":"https://www.scotusblog.com/2024/10/court-turns-down-bidens-bid-for-intervention-in-texas-emergency-abortion-dispute/"},{"name":"Legal Information Institute (Cornell Law School)","href":"https://www.law.cornell.edu/uscode/text/42/1395dd"}]},"federal_lands_military_va":{"military":{"title":"DoD funds restricted; travel policy rescinded","summary":"10 U.S.C. § 1093 prohibits use of DoD funds for most abortions in military facilities (life exception only); Secretary Hegseth rescinded the Biden-era travel and leave policy in January 2025, ending reimbursement for servicemembers who travel to obtain abortions.","description":"Federal law prohibits the use of Department of Defense funds to perform abortions at military medical facilities, except when the life of the pregnant person is endangered. This has been the law since 1984. After Dobbs, the Biden administration adopted a policy in October 2022 that allowed servicemembers and dependents stationed in states with abortion bans to get paid leave and travel reimbursement to go to another state for abortion care. In January 2025, Defense Secretary Hegseth rescinded that policy. As a result, military personnel and their families stationed in ban states must now pay for their own travel if they seek an abortion in another state.","verification":"semi_verified","confidence":"high","sources":[{"name":"U.S. House of Representatives (uscode.house.gov)","href":"https://uscode.house.gov/view.xhtml?req=(title:10%20section:1093%20edition:prelim)%20OR%20(granuleid:USC-prelim-title10-section1093)&f=treesort&num=0&edition=prelim"},{"name":"Congressional Research Service","href":"https://www.congress.gov/crs_external_products/IN/PDF/IN12512/IN12512.3.pdf"}]},"veterans_affairs":{"title":"VA abortion care banned; 2022 rule rescinded","summary":"The VA's 2022 interim final rule allowing abortion counseling and limited abortion services was replaced by a final rule in December 2025 reinstating the full ban on abortion in the VA medical benefits package, restoring the pre-2022 status.","description":"Before September 2022, the Department of Veterans Affairs did not provide abortion services or counseling to veterans. After Dobbs, the Biden administration issued an interim final rule allowing VA to provide abortion counseling and—in limited circumstances—abortion services to veterans and their beneficiaries, specifically in cases of rape, incest, or life or health endangerment. The Trump administration reversed this policy. In August 2025, the VA proposed a new rule restoring the full ban on abortion and abortion counseling. That rule was finalized in December 2025, meaning the VA once again cannot offer abortion counseling or abortion care to veterans.","verification":"semi_verified","confidence":"high","sources":[{"name":"Federal Register (via federalregister.gov)","href":"https://www.federalregister.gov/documents/2025/12/31/2025-24061/reproductive-health-services"}]},"federal_lands_and_facilities":{"title":"No federal-land clinic policy; state law applies","summary":"No federal statute or regulation authorizes abortion services on federal lands within ban states; the Assimilative Crimes Act, 18 U.S.C. § 13, incorporates state criminal law for acts on federal enclaves, making state abortion bans likely enforceable on most federal properties.","description":"Some advocates proposed that the Biden administration could allow abortion services on federal lands—like national parks or military bases—within states that ban abortion, arguing federal jurisdiction would override state law. The Biden administration did not adopt this approach, and no federal agency has authorized abortion services on federal lands specifically to circumvent state bans. The general legal rule is that state criminal law applies on federal lands through a law called the Assimilative Crimes Act, meaning state abortion bans would apply on federal property within that state. The legal picture is complex and depends on whether the land has exclusive or concurrent federal jurisdiction and when it was acquired, but the practical bottom line is that federal lands are not currently being used as abortion-access zones and would face significant legal obstacles if tried.","verification":"semi_verified","confidence":"high","sources":[{"name":"U.S. House of Representatives (uscode.house.gov)","href":"https://uscode.house.gov/view.xhtml?req=(title:18%20section:13%20edition:prelim)"}]},"federal_prisons_ihs":{"title":"Hyde restrictions apply; IHS limited to life","summary":"The Bureau of Prisons is bound by the Hyde Amendment and funds only 'medically necessary' abortions (life-endangerment); the Indian Health Service is similarly restricted by the Hyde Amendment, permitting abortions only in cases of rape, incest, or life endangerment when certified by a physician.","description":"People in federal prison have a constitutional right to abortion access, but the Bureau of Prisons is bound by the Hyde Amendment—meaning federal funds can only pay for abortions in cases of life endangerment. Inmates must pay for abortions in cases of rape or incest. As a practical matter, access depends heavily on the state where the prison is located and BOP's willingness to facilitate off-site care. For Native Americans served by the Indian Health Service, federal law (the Hyde Amendment, applied through the IHS appropriations statute, 25 U.S.C. § 1676) also strictly limits abortion funding. The IHS issued a circular in August 2022 clarifying that IHS funds may be used for abortions only in cases of rape, incest, or life endangerment, with physician certification required.","verification":"verified","confidence":"medium","sources":[{"name":"Indian Health Service","href":"https://www.ihs.gov/ihm/circulars/2022/use-of-indian-health-service-funds-for-abortions"},{"name":"Kansas Federal Public Defender","href":"https://ks.fd.org/blog/2024/08/8713-reproductive-health-rights-bop-what-rights-can-clients-invoke-referencing-bops"}]}},"interstate_questions":{"right_to_travel":{"title":"Presumed protected; Kavanaugh concurrence","summary":"Justice Kavanaugh's Dobbs concurrence states that a state may not bar a resident from traveling to another state for an abortion under the constitutional right to interstate travel; no Supreme Court majority has held this, but it represents the Court's currently expressed understanding.","description":"Justice Brett Kavanaugh wrote in his separate opinion in the Dobbs case that, in his view, a state cannot stop its residents from traveling to another state to get an abortion—he said the constitutional right to interstate travel protects that freedom. This was not the official holding of the Court, but it is the most direct statement any Justice has written on the question. No law currently in effect has tried to ban interstate travel for abortion, and no court has had to rule on it yet. But various people and groups have proposed laws that would penalize crossing state lines for abortion—for example, by allowing lawsuits against people who help someone travel. Such laws would face significant constitutional challenges under the right to travel, the Due Process Clause, and the Dormant Commerce Clause. For now, traveling for an abortion remains legally protected in practice, but the question has not been tested in court.","verification":"verified","confidence":"medium","sources":[{"name":"Supreme Court of the United States (via Akhil Amar site)","href":"https://akhilamar.com/wp-content/uploads/2023/09/Kavanaugh-concurrence-Dobbs.pdf"}]},"extraterritorial_state_laws":{"title":"Unresolved; multiple constitutional theories","summary":"No federal court has ruled whether states can extend their abortion laws to conduct in other states; Dormant Commerce Clause, due process, and full faith and credit doctrines would all limit state extraterritorial reach, but the question is unsettled.","description":"After Dobbs, some states and advocates have explored laws that would try to punish out-of-state conduct related to abortion—for example, suing someone who helps a resident travel to another state, or prosecuting a doctor in another state who provides abortion care to a resident. No state has actually enacted a law like this yet, and no federal court has ruled on whether one would be constitutional. But multiple federal constitutional doctrines would likely stand in the way: the Constitution gives Congress, not states, the power to regulate commerce between states (the Dormant Commerce Clause); the Due Process Clause limits a state's ability to regulate conduct outside its borders; and the Full Faith and Credit Clause generally does not require one state to enforce another state's criminal laws. If a state does try to reach across its borders, the legal fight would almost certainly end up in federal court and could take years to resolve.","verification":"verify_before_publication","confidence":"medium","sources":[{"name":"Justia","href":"https://supreme.justia.com/cases/federal/us/598/356/"}]},"shield_law_conflicts":{"title":"Interstate clashes brewing; unresolved","summary":"States with abortion 'shield' laws protecting providers from out-of-state subpoenas and extradition are on a collision course with ban states seeking to investigate cross-border abortion care; federal courts have not yet resolved which sovereign prevails.","description":"Some states that protect abortion rights have passed 'shield laws' that say their officials will not cooperate with out-of-state investigations or extradition requests related to abortion care lawfully provided within their borders. States that ban abortion, on the other hand, might try to subpoena records from shield-state clinics or seek to extradite shield-state doctors. This creates a direct interstate conflict. Federal courts have not yet resolved these clashes. The key federal legal questions include: whether the Extradition Clause requires one state to surrender a person charged with a crime in another state; whether the Full Faith and Credit Clause requires recognition of another state's judgments; and whether a doctor in a shield state can challenge a ban-state subpoena in federal court. In early 2025, Texas sought to subpoena a New York doctor who provided abortion pills via telehealth; New York's shield law and governor blocked cooperation. Several cases are expected to bring these questions before federal courts.","verification":"verify_before_publication","confidence":"medium","sources":[{"name":"Justia","href":"https://supreme.justia.com/cases/federal/us/483/219/"}]}},"congressional_activity":{"title":"Riders are law; no national ban or codification","summary":"No national abortion ban or codification has been enacted; appropriations riders (Hyde, Weldon, Helms) remain the operative federal legislative tools; bills proposing national 15-week bans, fetal-personhood laws, and the Women's Health Protection Act have been introduced but lack the votes for passage.","description":"Congress has not passed a national law either banning abortion or protecting it. The main tool Congress uses is the appropriations process—the annual spending bills that include restrictions like the Hyde Amendment and the Weldon Amendment. Several bills have been introduced: the Women's Health Protection Act, which would create a federal statutory right to abortion, has been reintroduced in every recent Congress but cannot overcome the Senate filibuster. On the other side, Senator Graham proposed a 15-week national ban in 2022, and the Life at Conception Act (H.R. 722) was introduced in January 2025, declaring that the right to life begins at fertilization. None of these have passed. The Born-Alive Abortion Survivors Protection Act (H.R. 21) passed the House in January 2025 but has not passed the Senate. The realistic picture is that Congress remains gridlocked on abortion legislation; the spending riders are the only federal laws that reliably continue year after year.","verification":"semi_verified","confidence":"high","sources":[{"name":"Congress.gov","href":"https://www.congress.gov/bill/119th-congress/house-bill/12/text"},{"name":"Congress.gov","href":"https://www.congress.gov/bill/119th-congress/house-bill/722"},{"name":"GovTrack.us","href":"https://www.govtrack.us/congress/bills/119/hr21"}]}},"penalties":[{"actor":"Physician performing a partial-birth abortion (non-life-saving)","offense":"Knowingly performing a partial-birth abortion in violation of 18 U.S.C. § 1531","penalty":"Fine under Title 18, imprisonment up to 2 years, or both; civil liability for money damages, including statutory damages of three times the cost of the procedure, to the father or maternal grandparents","verification":"verified","sources":[{"name":"Legal Information Institute (Cornell Law School)","href":"https://www.law.cornell.edu/uscode/text/18/1531"}]},{"actor":"Pregnant woman upon whom a partial-birth abortion is performed","offense":"Expressly exempt from prosecution under 18 U.S.C. § 1531(e)","penalty":"None — statute explicitly prohibits prosecution of the woman under § 1531, for conspiracy to violate it, or for aiding and abetting","verification":"verified","sources":[{"name":"Legal Information Institute (Cornell Law School)","href":"https://www.law.cornell.edu/uscode/text/18/1531"}]},{"actor":"Person who mails or ships abortion-related articles with unlawful intent","offense":"Mailing nonmailable abortion-related matter under 18 U.S.C. § 1461 or using a common carrier under § 1462","penalty":"Fine under Title 18, imprisonment up to 5 years (for first offense), or both (under § 1461); same for § 1462","verification":"verified","sources":[{"name":"Legal Information Institute (Cornell Law School)","href":"https://www.law.cornell.edu/uscode/text/18/1461"}]},{"actor":"Person who obstructs, threatens, or uses force against abortion clinic patients or providers","offense":"Violating the FACE Act, 18 U.S.C. § 248(a)(1)","penalty":"First offense: fine or imprisonment up to 1 year, or both; subsequent: up to 3 years; nonviolent physical obstruction: fine up to $10,000 and up to 6 months; if bodily injury results: up to 10 years; if death results: any term of years or life","verification":"verified","sources":[{"name":"Legal Information Institute (Cornell Law School)","href":"https://www.law.cornell.edu/uscode/text/18/248"}]},{"actor":"Health care provider or entity receiving federal HHS funds who refuses to perform or assist in abortion","offense":"Protected conduct; no offense committed — protected by Church Amendments (42 U.S.C. § 300a-7) and Coats-Snowe (42 U.S.C. § 238n)","penalty":"None for the refuser; any entity discriminating against a refuser is subject to loss of federal financial assistance","verification":"verified","sources":[{"name":"U.S. House of Representatives (uscode.house.gov)","href":"https://uscode.house.gov/view.xhtml?req=granuleid%3AUSC-prelim-title42-section300a-7&num=0&edition=prelim"}]}],"recent_changes":[{"date":"2022-06-24","event":"Supreme Court decides Dobbs v. Jackson Women's Health Organization, overruling Roe v. Wade and Planned Parenthood v. Casey; holds Constitution does not confer a right to abortion; returns regulation to the states.","sources":[{"name":"Supreme Court of the United States","href":"https://www.supremecourt.gov/opinions/21pdf/19-1392_6j37.pdf"}]},{"date":"2022-07-08","event":"President Biden signs Executive Order 14076, 'Protecting Access to Reproductive Healthcare Services,' directing HHS and other agencies to identify ways to protect and expand abortion access, including through EMTALA enforcement and medication abortion.","sources":[{"name":"The White House / Federal Register","href":"https://www.presidency.ucsb.edu/documents/executive-order-14076-protecting-access-reproductive-health-care-services"}]},{"date":"2022-07-11","event":"CMS issues EMTALA guidance stating that EMTALA preempts state abortion bans when abortion is necessary to stabilize a pregnant patient's emergency medical condition.","sources":[{"name":"Centers for Medicare & Medicaid Services","href":"https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and-memos-states-and/reinforcement-emtala-obligations-specific-patients-who-are-pregnant-or-are-experiencing-pregnancy-0"}]},{"date":"2022-09-09","event":"VA issues interim final rule removing long-standing exclusions on abortion counseling and permitting abortion services in cases of rape, incest, or life/health endangerment for veterans and CHAMPVA beneficiaries.","sources":[{"name":"Federal Register","href":"https://www.federalregister.gov/documents/2022/09/09/2022-19673/reproductive-health-services"}]},{"date":"2022-10-20","event":"Secretary of Defense Austin issues memorandum establishing paid administrative leave and travel allowances for servicemembers and dependents who must travel to access non-covered reproductive health care.","sources":[{"name":"U.S. Department of Defense","href":"https://www.defense.gov/News/Releases/Release/Article/3194507/"}]},{"date":"2022-12-23","event":"DOJ Office of Legal Counsel issues opinion concluding that the Comstock Act, 18 U.S.C. § 1461, does not prohibit mailing mifepristone and misoprostol where the sender lacks intent that the drugs be used unlawfully.","sources":[{"name":"U.S. Department of Justice, Office of Legal Counsel","href":"https://www.justice.gov/olc/opinion/file/1560596/dl"}]},{"date":"2023-01-03","event":"FDA permanently removes the in-person dispensing requirement for mifepristone and adds a pharmacy certification process, enabling certified retail and mail-order pharmacies to dispense the drug.","sources":[{"name":"U.S. Food and Drug Administration (accessdata.fda.gov)","href":"https://www.accessdata.fda.gov/drugsatfda_docs/summary_review/2023/020687Orig1s025SumR.pdf"}]},{"date":"2024-01-02","event":"Fifth Circuit affirms district court injunction blocking enforcement of CMS EMTALA abortion guidance in Texas (Texas v. Becerra).","sources":[{"name":"U.S. Court of Appeals for the Fifth Circuit","href":"https://www.ca5.uscourts.gov/opinions/pub/23/23-10246-CV0.pdf"}]},{"date":"2024-06-13","event":"Supreme Court unanimously holds in FDA v. Alliance for Hippocratic Medicine that anti-abortion doctors lack Article III standing to challenge FDA's mifepristone regulation, preserving current access.","sources":[{"name":"Supreme Court of the United States","href":"https://www.supremecourt.gov/opinions/23pdf/23-235_n7lp.pdf"}]},{"date":"2024-06-27","event":"Supreme Court dismisses Moyle v. United States as improvidently granted, vacating its stay; district court preliminary injunction against Idaho's abortion ban resumes; EMTALA preemption question remains unresolved.","sources":[{"name":"Supreme Court of the United States","href":"https://www.supremecourt.gov/opinions/23pdf/23-726_6jgm.pdf"}]},{"date":"2024-10-07","event":"Supreme Court denies certiorari in Texas v. Becerra, leaving in place the Fifth Circuit's decision blocking CMS EMTALA guidance enforcement in Texas.","sources":[{"name":"SCOTUSblog","href":"https://www.scotusblog.com/2024/10/court-turns-down-bidens-bid-for-intervention-in-texas-emergency-abortion-dispute/"}]},{"date":"2025-01-24","event":"President Trump signs Executive Order 14182, 'Enforcing the Hyde Amendment,' rescinding Biden-era EOs 14076 and 14079 and directing agencies to end federal funding or promotion of elective abortion; same day, DOJ issues memorandum sharply limiting FACE Act enforcement.","sources":[{"name":"The White House","href":"https://www.whitehouse.gov/presidential-actions/2025/01/enforcing-the-hyde-amendment"},{"name":"U.S. Department of Justice","href":"https://www.justice.gov/media/1386461/dl"}]},{"date":"2025-01-30","event":"Secretary of Defense Hegseth rescinds Biden-era policy providing travel allowances and paid leave for servicemembers traveling for non-covered reproductive health care.","sources":[{"name":"Congressional Research Service","href":"https://www.congress.gov/crs_external_products/IN/PDF/IN12512/IN12512.3.pdf"}]},{"date":"2025-07-15","event":"Fourth Circuit holds in GenBioPro v. Raynes that FDA regulation of mifepristone does not preempt West Virginia's near-total abortion ban, rejecting conflict-preemption and obstacle-preemption theories.","sources":[{"name":"Justia","href":"https://law.justia.com/cases/federal/appellate-courts/ca4/23-2194/23-2194-2025-07-15.html"}]},{"date":"2025-12-31","event":"VA finalizes rule reinstating the full exclusion on abortion and abortion counseling from the VA medical benefits package and CHAMPVA, reversing the 2022 interim final rule.","sources":[{"name":"Federal Register","href":"https://www.federalregister.gov/documents/2025/12/31/2025-24061/reproductive-health-services"}]}],"pending_changes":[{"name":"Missouri v. FDA (E.D. Mo.)","type":"litigation","status":"States of Missouri, Idaho, and Kansas challenge FDA's approval and regulation of mifepristone under the APA, FDCA, and Comstock Act; case transferred from N.D. Tex. to E.D. Mo. in October 2025; amended complaint filed; pending motion practice.","effect":"If successful, could result in nationwide restrictions on mifepristone, including reinstatement of pre-2016 REMS conditions, limitations on telehealth prescribing, or a finding that FDA violated the Comstock Act.","sources":[{"name":"Health Care Litigation Tracker (Georgetown Law)","href":"https://litigationtracker.law.georgetown.edu/litigation/state-of-missouri-et-al-v-food-and-drug-administration-et-al"}]},{"name":"United States v. Idaho / Moyle v. United States (9th Cir.)","type":"litigation","status":"On remand following Supreme Court's DIG; district court preliminary injunction against Idaho's abortion ban remains in effect; Ninth Circuit to decide merits of EMTALA preemption.","effect":"A Ninth Circuit ruling on EMTALA preemption could either strengthen or weaken the federal government's ability to require emergency abortion care in ban states; a circuit split with the Fifth Circuit could prompt Supreme Court review.","sources":[{"name":"SCOTUSblog","href":"https://www.scotusblog.com/cases/moyle-v-united-states-2"}]},{"name":"GenBioPro v. Raynes — potential Supreme Court petition","type":"litigation","status":"Fourth Circuit issued 2-1 decision July 2025 rejecting preemption; GenBioPro may seek en banc review or file a certiorari petition at the Supreme Court.","effect":"Supreme Court review could definitively resolve whether FDA approval of mifepristone preempts state abortion bans, a question with nationwide implications for medication abortion access.","sources":[{"name":"Justia","href":"https://law.justia.com/cases/federal/appellate-courts/ca4/23-2194/23-2194-2025-07-15.html"}]},{"name":"Bryant v. Stein — North Carolina mifepristone preemption","type":"litigation","status":"Pending in the Fourth Circuit; involves a challenge by a physician to North Carolina's medication abortion restrictions on preemption grounds. Briefing underway; held pending GenBioPro resolution.","effect":"A ruling that North Carolina's restrictions are preempted could create a circuit split with the GenBioPro panel, increasing the likelihood of Supreme Court review on the preemption question.","sources":[{"name":"UCLA Law Mifepristone Litigation Tracker","href":"https://law.ucla.edu/sites/default/files/images/CRHLP%20Mifepristone%20Litigation%20and%20Federal%20Action%20Tracker%20Sept%202025%20update.pdf"}]},{"name":"Born-Alive Abortion Survivors Protection Act (H.R. 21)","type":"legislation","status":"Passed the House on January 23, 2025 (217-204); pending in the Senate. Requires health care practitioners to provide the same degree of professional skill and care to a child born alive after an abortion as would be provided to any other child born alive at the same gestational age.","effect":"Would impose federal criminal penalties on practitioners who fail to provide care to infants born alive after abortion; opponents argue existing federal born-alive protections already exist under 1 U.S.C. § 8 and that the bill is redundant and could intimidate providers.","sources":[{"name":"GovTrack.us","href":"https://www.govtrack.us/congress/bills/119/hr21"}]},{"name":"Potential rescission or revision of CMS EMTALA abortion guidance","type":"rule_making","status":"The July 2022 CMS EMTALA guidance remains on the books but the Trump administration has not actively defended it in litigation; the Hyde Amendment Executive Order (EO 14182) directs agencies to end federal funding or promotion of elective abortion.","effect":"Formal rescission of the guidance would eliminate the federal government's position that EMTALA requires emergency abortion care in ban states, though the underlying statutory question would remain for courts to decide.","sources":[{"name":"The White House","href":"https://www.whitehouse.gov/presidential-actions/2025/01/enforcing-the-hyde-amendment"}]}],"key_authorities":[{"name":"Dobbs v. Jackson Women's Health Organization","citation":"597 U.S. 215 (2022)","type":"case","url":"https://www.supremecourt.gov/opinions/21pdf/19-1392_6j37.pdf","why":"Overruled Roe and Casey, eliminating the federal constitutional right to abortion and returning abortion regulation to states and Congress under rational-basis review."},{"name":"Dobbs v. Jackson Women's Health Org. (Kavanaugh, J., concurring)","citation":"597 U.S. ___ (2022)","type":"case","url":"https://akhilamar.com/wp-content/uploads/2023/09/Kavanaugh-concurrence-Dobbs.pdf","why":"The closest authority on whether states may bar interstate travel for abortion; Kavanaugh stated the answer is 'no' based on the constitutional right to interstate travel."},{"name":"Partial-Birth Abortion Ban Act of 2003","citation":"18 U.S.C. § 1531","type":"statute","url":"https://www.law.cornell.edu/uscode/text/18/1531","why":"The only federal statute criminalizing a specific abortion procedure nationwide; bans intact D&X with a life exception and exempts the pregnant woman."},{"name":"Gonzales v. Carhart","citation":"550 U.S. 124 (2007)","type":"case","url":"https://supreme.justia.com/cases/federal/us/550/124/","why":"Upheld the Partial-Birth Abortion Ban Act against a facial constitutional challenge, marking the first time the Supreme Court upheld a federal abortion restriction lacking a health exception."},{"name":"Comstock Act (mailing prohibition)","citation":"18 U.S.C. §§ 1461-1462","type":"statute","url":"https://www.law.cornell.edu/uscode/text/18/1461","why":"Foundational prohibition on mailing abortion-related articles; its application to medication abortion remains subject to interpretive debate and potential revival."},{"name":"DOJ OLC Opinion on Comstock Act (Dec. 23, 2022)","citation":"46 Op. O.L.C. __ (Dec. 23, 2022)","type":"agency_action","url":"https://www.justice.gov/olc/opinion/file/1560596/dl","why":"Current executive-branch interpretation that the Comstock Act does not prohibit mailing abortion drugs absent unlawful intent; subject to change by a future administration."},{"name":"FDA v. Alliance for Hippocratic Medicine","citation":"602 U.S. 367 (2024)","type":"case","url":"https://www.supremecourt.gov/opinions/23pdf/23-235_n7lp.pdf","why":"Unanimous Supreme Court standing ruling that preserved current mifepristone access without reaching the merits of FDA's regulatory decisions."},{"name":"GenBioPro, Inc. v. Raynes","citation":"No. 23-2194 (4th Cir. July 15, 2025)","type":"case","url":"https://law.justia.com/cases/federal/appellate-courts/ca4/23-2194/23-2194-2025-07-15.html","why":"First federal appellate ruling that FDA regulation of mifepristone does not preempt state abortion bans; may be appealed to the Supreme Court."},{"name":"Moyle v. United States","citation":"603 U.S. 324 (2024) (per curiam)","type":"case","url":"https://www.supremecourt.gov/opinions/23pdf/23-726_6jgm.pdf","why":"Supreme Court dismissed the EMTALA preemption case as improvidently granted, leaving the core preemption question unresolved and the district court injunction in place."},{"name":"EMTALA","citation":"42 U.S.C. § 1395dd","type":"statute","url":"https://www.law.cornell.edu/uscode/text/42/1395dd","why":"Federal statute requiring stabilizing treatment in hospital emergency departments; its application to emergency abortion care in ban states is the central unresolved post-Dobbs federal question."},{"name":"Hyde Amendment (annual appropriations rider)","citation":"See, e.g., Consolidated Appropriations Act, 2024, Pub. L. No. 118-42, Div. D, §§ 506-507","type":"statute","url":"https://www.congress.gov/crs-product/IF12167","why":"The operative federal funding restriction barring most federal abortion expenditures with rape, incest, and life exceptions; must be reenacted annually."},{"name":"Church Amendments","citation":"42 U.S.C. § 300a-7","type":"statute","url":"https://uscode.house.gov/view.xhtml?req=granuleid%3AUSC-prelim-title42-section300a-7&num=0&edition=prelim","why":"Foundational federal conscience protection shielding individuals and entities from being required to participate in abortion contrary to religious or moral convictions."},{"name":"Coats-Snowe Amendment","citation":"42 U.S.C. § 238n","type":"statute","url":"https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section238n&num=0&edition=prelim","why":"Prohibits government discrimination against health care entities and training programs that refuse to perform, train in, or refer for abortions."},{"name":"Born-Alive Infants Protection Act","citation":"1 U.S.C. § 8","type":"statute","url":"https://www.govinfo.gov/link/uscode/1/8","why":"Defines 'born alive' for all federal law purposes, explicitly reserving the question of legal status before birth."},{"name":"Unborn Victims of Violence Act","citation":"18 U.S.C. § 1841","type":"statute","url":"https://uscode.house.gov/view.xhtml?req=(title:18%20section:1841%20edition:prelim)%20OR%20(granuleid:USC-prelim-title18-section1841)&f=treesort&num=0&edition=prelim","why":"Creates federal fetal-homicide liability for certain crimes while expressly excluding consensual abortion and the pregnant woman from liability."},{"name":"FACE Act","citation":"18 U.S.C. § 248","type":"statute","url":"https://www.law.cornell.edu/uscode/text/18/248","why":"Federal criminal prohibition on force, threats, or obstruction against reproductive health clinics, providers, and patients; enforcement significantly curtailed under current DOJ policy."},{"name":"DoD Abortion Funding Restriction","citation":"10 U.S.C. § 1093","type":"statute","url":"https://uscode.house.gov/view.xhtml?req=(title:10%20section:1093%20edition:prelim)%20OR%20(granuleid:USC-prelim-title10-section1093)&f=treesort&num=0&edition=prelim","why":"Restricts use of DoD funds for abortion to life-endangerment cases only; travel reimbursement policy rescinded in 2025."},{"name":"Executive Order 14182 (Enforcing the Hyde Amendment)","citation":"Exec. Order No. 14182, 90 Fed. Reg. ___ (Jan. 24, 2025)","type":"executive_action","url":"https://www.whitehouse.gov/presidential-actions/2025/01/enforcing-the-hyde-amendment","why":"Rescinded Biden-era reproductive health EOs and directed all agencies to enforce Hyde restrictions strictly, signaling a broad shift in federal enforcement posture."}],"research_notes":{"overall_confidence":"high","editor_notes":"This analysis is current through July 16, 2025. Key items requiring re-verification before publication: (1) Whether the FY 2026 appropriations acts include Hyde, Weldon, and other riders in their traditional form; (2) whether CMS has formally rescinded or revised the July 2022 EMTALA abortion guidance; (3) the status of any certiorari petition in GenBioPro v. Raynes; (4) any substantive rulings in the Missouri v. FDA litigation in the Eastern District of Missouri; (5) whether the VA final rule (Dec. 31, 2025) was challenged under the Congressional Review Act and the outcome; (6) the status of the Born-Alive Abortion Survivors Protection Act in the Senate; (7) whether any new OLC opinion has been issued modifying or withdrawing the December 2022 Comstock Act opinion. The Helms Amendment's interpretation in practice goes beyond its text (barring 'abortion as a method of family planning' but in practice barring all abortion funding in foreign aid); this discrepancy should be noted to readers.","gaps":["The Bureau of Prisons' current formal program statement on abortion services was not located in full text; BOP policy documents were under revision as of early 2025 and the precise current status of inmate abortion access policies should be verified with the latest BOP Program Statement on Patient Care.","The CMS EMTALA abortion guidance from July 2022 has not been formally rescinded as of this research date, but the Trump administration's enforcement posture is unclear; an editor should verify whether a formal rescission has occurred since this research was completed.","Whether GenBioPro will petition for Supreme Court review of the Fourth Circuit's July 2025 decision is not yet known; editors should monitor the docket for a certiorari petition deadline (typically 90 days from judgment).","Several shield-law interstate conflict scenarios are developing in real time (e.g., Texas subpoenas to New York telehealth providers) with no federal court rulings yet; these should be tracked as they develop.","The IHS Circular No. 22-15 (August 2022) remains in effect but may be revised or rescinded under the Trump administration's Hyde Executive Order; editors should monitor IHS circulars for any update."]}}